News

Ochre Bio, an innovator in chronic liver disease drug development, announced the successful close of $30M in Series A financing. The investor syndicate included investors Khosla…
Read More...

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced that the U.S. Food and Drug Administration…
Read More...

STALICLA SA, a precision neuroscience clinical stage biotech, advancing the first precision medicine platform (DEPI) for patients with Neurodevelopmental Disorders (NDDs), announced the…
Read More...

Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical…
Read More...

Surrozen, Inc. announced that it has entered into a collaboration and license agreement with Boehringer Ingelheim to research and develop SZN-413 for the treatment of retinal diseases.…
Read More...

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of tirzepatide for the treatment of adults with…
Read More...

Sanofi US has announced it has entered into a co-promotion service agreement with Provention Bio, Inc., for the commercialization of teplizumab in the United States. Teplizumab,…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic,…
Read More...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that its Life Science business sector…
Read More...

Tempus announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical stage biopharmaceutical company, in support of its ongoing Phase…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today issued the following announcement regarding data from two real-world evidence studies…
Read More...

Enzo Biochem, Inc. announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York. The launch event…
Read More...

Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies.…
Read More...

CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, announced the latest funding award under…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases…
Read More...

BioLink Life Sciences of Cary, North Carolina, announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the development of…
Read More...

Pfizer Inc. announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID),…
Read More...

Myonex announced the completion of its acquisition of the clinical trial and packaging business of Hubertus Apotheke, located in Berlin, Germany. The new entity, Myonex GmbH, supports…
Read More...

Almac Clinical Services, a member of The Almac Group, the global contract development and manufacturing organisation, announces a new state-of-the-art Cryogenic Service Solution within…
Read More...